Metastatic Basal Cell Skin Cancer

Metastatic Basal Cell Skin Cancer - most related articles:

- Erivedge approved for skin cancer metastatic basal cell carcinoma - 11.9
- Vitamin D deficiency linked to skin cancer - 10
- A new therapy to cure skin cancer - 7.1
- Tanning bed ban for minors under 18 in California US - 6.4
- Melanoma skin cancer rising in Victoria - 6.3
- Breast cells responsible for breast cancers - 6.1
- Celebrex may prevent some non melanoma skin cancers - 5.7
- Skin odor may diagnose skin cancer - 5.6
- Melanoma skin cancer triggered by BRAF gene mutation - 5.4
- Sulforaphane in broccoli could treat genetic skin disorder - 5.3

Metastatic Basal Cell Skin Cancer articles

Erivedge approved for skin cancer metastatic basal cell carcinoma
Erivedge or vismodegib was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The Erivedge drug is intended for use in patients with locally advanced basal cell cancer who are not candidates for surgery or radiation and for patients whose cancer has spread to other parts of the body (metastatic).

A new therapy to cure skin cancer
A potential new investigational therapy for advanced and metastatic basal cell skin cancer is revealed by researchers.

2 Metastatic Basal Cell Skin Cancer articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
4.99